These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21370436)

  • 1. Long-term hepatic outcomes in survivors of stage 4S and 4 neuroblastoma in infancy.
    French AE; Irwin MS; Navarro OM; Greenberg M; Nathan PC
    Pediatr Blood Cancer; 2012 Feb; 58(2):283-8. PubMed ID: 21370436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver involvement in neuroblastoma: the Memorial Sloan-Kettering Experience supports treatment reduction in young patients.
    Kushner BH; Kramer K; LaQuaglia MP; Modak S; Cheung NK
    Pediatr Blood Cancer; 2006 Mar; 46(3):278-84. PubMed ID: 16124002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatopathy in patients with stage 4S neuroblastoma].
    Claviez A; Hero B; Schneppenheim R; Berthold F
    Klin Padiatr; 1996; 208(4):221-8. PubMed ID: 8926687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival and late effects in children with stage 4 neuroblastoma.
    Perwein T; Lackner H; Sovinz P; Benesch M; Schmidt S; Schwinger W; Urban C
    Pediatr Blood Cancer; 2011 Oct; 57(4):629-35. PubMed ID: 21319289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes in patients with stage IV neuroblastoma.
    Escobar MA; Grosfeld JL; Powell RL; West KW; Scherer LR; Fallon RJ; Rescorla FJ
    J Pediatr Surg; 2006 Feb; 41(2):377-81. PubMed ID: 16481255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term complications in survivors of advanced stage neuroblastoma.
    Laverdière C; Cheung NK; Kushner BH; Kramer K; Modak S; LaQuaglia MP; Wolden S; Ness KK; Gurney JG; Sklar CA
    Pediatr Blood Cancer; 2005 Sep; 45(3):324-32. PubMed ID: 15714447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sequential treatment algorithm for infants with stage 4s neuroblastoma and massive hepatomegaly.
    Weintraub M; Waldman E; Koplewitz B; Bloom AI; Gross E; Freeman AI; Revel-Vilk S
    Pediatr Blood Cancer; 2012 Jul; 59(1):182-4. PubMed ID: 22605456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroblastoma in adolescents: the Italian experience.
    Conte M; Parodi S; De Bernardi B; Milanaccio C; Mazzocco K; Angelini P; Viscardi E; Di Cataldo A; Luksch R; Haupt R
    Cancer; 2006 Mar; 106(6):1409-17. PubMed ID: 16475209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of prognostic factors in the Austrian A-NB87 Neuroblastoma Study].
    Ladenstein R; Ambros PF; Urban C; Ambros IM; Fink FM; Zoubek A; Grienberger H; Schmitt K; Kerbl R; Horcher E; Amann G; Höfler G; Heinzl H; Gadner H; Mutz I
    Klin Padiatr; 1996; 208(4):210-20. PubMed ID: 8926686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroblastoma in Turkish children: experience of a single center.
    Aydn GB; Kutluk MT; Yalçn B; Büyükpamukçu M; Kale G; Varan A; Akyüz C; Senocak ME; Büyükpamukçu N
    J Pediatr Hematol Oncol; 2009 Jul; 31(7):471-80. PubMed ID: 19564739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of therapy for stage C neuroblastoma.
    Halperin EC
    J Surg Oncol; 1996 Nov; 63(3):172-8. PubMed ID: 8944061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
    Schmidt ML; Lal A; Seeger RC; Maris JM; Shimada H; O'Leary M; Gerbing RB; Matthay KK
    J Clin Oncol; 2005 Sep; 23(27):6474-80. PubMed ID: 16116154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroblastoma 4S: a heterogeneous disease with variable risk factors and treatment strategies.
    van Noesel MM; Hählen K; Hakvoort-Cammel FG; Egeler RM
    Cancer; 1997 Sep; 80(5):834-43. PubMed ID: 9307181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of natural antibody against human neuroblastoma among children with or without neuroblastoma.
    Fukuda M; Nozaki C; Ishiguro Y; Horibe K
    Med Pediatr Oncol; 2001 Jan; 36(1):147-8. PubMed ID: 11464870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic neuroblastoma.
    Kushner BH; Kramer K; Cheung NK
    Cancer; 2002 Sep; 95(6):1366-75. PubMed ID: 12216106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of DNA di-tetraploidy in neuroblastoma.
    Ladenstein R; Ambros IM; Pötschger U; Amann G; Urban C; Fink FM; Schmitt K; Jones R; Slociak M; Schilling F; Ritter J; Berthold F; Gadner H; Ambros PF
    Med Pediatr Oncol; 2001 Jan; 36(1):83-92. PubMed ID: 11464912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of Ab3 and Ab3' antibody was associated with long-term survival after anti-G(D2) antibody therapy of stage 4 neuroblastoma.
    Cheung NK; Guo HF; Heller G; Cheung IY
    Clin Cancer Res; 2000 Jul; 6(7):2653-60. PubMed ID: 10914706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of efficacy of treatment for 30 children with neuroblastoma].
    Sun XF; Liu DG; Su YS; Lin TY; Chen XQ; He YJ
    Ai Zheng; 2003 Dec; 22(12):1343-5. PubMed ID: 14693065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal nodular hyperplasia in children following treatment of hemato-oncologic diseases.
    Freidl T; Lackner H; Huber J; Sovinz P; Moser A; Schroettner B; Schwinger W; Urban C
    Klin Padiatr; 2008; 220(6):384-7. PubMed ID: 18949676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of bone marrow evaluation in the staging of patients with otherwise localized, low-risk neuroblastoma.
    Russell HV; Golding LA; Suell MN; Nuchtern JG; Strother DR
    Pediatr Blood Cancer; 2005 Dec; 45(7):916-9. PubMed ID: 16078212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.